Breaking News Instant updates and real-time market news.

VCYT

Veracyte

$73.88 /

-0.76 (-1.02%)

 16:12
02/17/21
 02/17
16:12
 02/17/21
16:12

Veracyte reports Q4 EPS (14c), consensus (11c)

Reports Q4 revenue $34.5M, consensus $31.93M. CEO Bonnie Anderson says: "Our revenue and genomic testing and product volume continued to rebound from the pandemic during the fourth quarter and we entered 2021 with strong momentum across our business. We are on track to launch multiple new products this year, including our noninvasive nasal swab test and Percepta Genomic Atlas in lung cancer. "

  • 17

    Feb

  • 17

    Feb

  • 05

    Aug

  • 05

    Feb

VCYT Veracyte
$73.88 /

-0.76 (-1.02%)

02/08/21 SVB Leerink
Veracyte price target raised to $83 from $40 at SVB Leerink
01/27/21 Truist
Veracyte initiated with a Buy at Truist
12/17/20 Lake Street
Veracyte price target raised to $60 from $40 at Lake Street
12/17/20 BTIG
Veracyte price target raised to $56 from $42 at BTIG

TODAY'S FREE FLY STORIES

Hot Stocks
Parsons awarded $2B ceiling Air Force Base modernization contract » 16:32
03/01/21
03/01
16:32
03/01/21
16:32
PSN

Parsons

$35.34 /

-0.485 (-1.35%)

Parsons was awarded an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PSN Parsons
$35.34 /

-0.485 (-1.35%)

02/24/21
Parsons falls -10.4%
02/24/21
Parsons falls -9.2%
02/22/21
Parsons awarded $600M USPS contract
02/09/21
Parsons wins $69M U.S. Army contract
PSN Parsons
$35.34 /

-0.485 (-1.35%)

02/25/21 Cowen
Parsons gives soft guidance, Cowen downgrades to Market Perform
02/25/21 Cowen
Parsons downgraded to Market Perform from Outperform at Cowen
05/05/20 Wells Fargo
Parsons price target raised to $39 from $33 at Wells Fargo
04/15/20 Benchmark
Parsons initiated with a Buy at Benchmark
PSN Parsons
$35.34 /

-0.485 (-1.35%)

02/24/21
Parsons sees FY21 revenue $3.85B-$4.05B, consensus $4.23B
02/24/21
Parsons reports Q4 adjusted EPS 51c, consensus 34c
11/04/20
Parsons backs FY20 revenue view $3.95B-$4.05B, consensus $4.01B
11/04/20
Parsons reports Q3 adj. EPS 57c, consensus 33c
PSN Parsons
$35.34 /

-0.485 (-1.35%)

02/24/21
Fly Intel: Pre-market Movers
11/16/20
Fly Insider: Cerevel Therapeutics, Paylocity among weeks notable insider trades
03/15/21
2021 Industrials Virtual Conference
Syndicate
Hamilton Lane 1.45M share Spot Secondary; price range $88.25-$89.25 » 16:32
03/01/21
03/01
16:32
03/01/21
16:32
HLNE

Hamilton Lane

$91.73 /

+2.24 (+2.50%)

JPMorgan is acting as…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HLNE Hamilton Lane
$91.73 /

+2.24 (+2.50%)

02/16/21
Hamilton Lane closes largest fund to-date
01/28/21
Hamilton Lane to acquire Denver-based 361 Capital
01/07/21
Hamilton Lane launches fund to expand access to private markets
HLNE Hamilton Lane
$91.73 /

+2.24 (+2.50%)

01/26/21 Morgan Stanley
Morgan Stanley downgrades Hamilton Lane to Equal Weight following outperformance
01/26/21 Morgan Stanley
Hamilton Lane downgraded to Equal Weight from Overweight at Morgan Stanley
01/11/21 Wells Fargo
Hamilton Lane price target raised to $77 from $70 at Wells Fargo
12/16/20 UBS
Hamilton Lane initiated with a Buy at UBS
HLNE Hamilton Lane
$91.73 /

+2.24 (+2.50%)

02/02/21
Hamilton Lane reports Q3 EPS 96c, consensus 57c
11/04/20
Hamilton Lane reports Q2 EPS 66c, consensus 60c
  • 02
    Sep
  • 03
    Jun
Hot Stocks
BWX Technologies awarded $57.5M NNSA contract » 16:32
03/01/21
03/01
16:32
03/01/21
16:32
BWXT

BWX Technologies

$59.96 /

+1.975 (+3.41%)

BWX Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BWXT BWX Technologies
$59.96 /

+1.975 (+3.41%)

12/23/20
BWX Technologies selected by DoD to lead $106.6M microreactor design project
11/10/20
BWX Technologies unit completes TRISO nuclear fuel restart project
11/02/20
BWXT reaffirms non-GAAP EPS CAGR view in low-double digits over three-five years
BWXT BWX Technologies
$59.96 /

+1.975 (+3.41%)

01/07/21 Baird
BWX Technologies downgraded to Neutral from Outperform at Baird
10/15/20 BofA
BWX Technologies upgraded to Buy from Neutral at BofA
10/15/20 BofA
BWX Technologies upgraded to Buy from Neutral at BofA
06/22/20 Maxim
BWX Technologies price target raised to $72 from $62 at Maxim
BWXT BWX Technologies
$59.96 /

+1.975 (+3.41%)

02/22/21
BWX Technologies sees FY21 EPS $3.05-$3.20, consensus $3.12
02/22/21
BWX Technologies reports Q4 EPS 74c, consensus 71c
11/02/20
BWX Technologies rasies FY20 non-GAAP EPS view to $3.00 from $2.80-$2.90
11/02/20
BWX Technologies reports Q3 non-GAAP EPS 79c, consensus 67c
Hot Stocks
Sherwin-Williams COO David Sewell resigns, effective March 12 » 16:31
03/01/21
03/01
16:31
03/01/21
16:31
SHW

Sherwin-Williams

$693.88 /

+12.15 (+1.78%)

The Sherwin-Williams…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHW Sherwin-Williams
$693.88 /

+12.15 (+1.78%)

02/18/21
Sherwin-Williams to divest Wattyl Business
02/17/21
Sherwin-Williams raises quarterly dividend to $1.65 per share
02/17/21
Sherwin-Williams board approves additinal 15M share repurchase authorization
02/03/21
Sherwin-Williams announces three-for-one stock split
SHW Sherwin-Williams
$693.88 /

+12.15 (+1.78%)

01/29/21 JPMorgan
Sherwin-Williams price target raised to $760 from $740 at JPMorgan
01/29/21 RBC Capital
Sherwin-Williams price target raised to $806 from $765 at RBC Capital
01/29/21 Credit Suisse
Sherwin-Williams price target raised to $874 from $845 at Credit Suisse
01/19/21 Wells Fargo
Sherwin-Williams initiated with an Overweight at Wells Fargo
SHW Sherwin-Williams
$693.88 /

+12.15 (+1.78%)

01/28/21
Sherwin-Williams sees FY21 adjusted EPS $26.40-$27.20, consensus $ 26.73
01/28/21
Sherwin-Williams reports Q4 adjusted EPS $5.09, consensus $4.85
01/27/21
Notable companies reporting before tomorrow's open
01/27/21
Notable companies reporting before tomorrow's open
SHW Sherwin-Williams
$693.88 /

+12.15 (+1.78%)

01/28/21
Fly Intel: Pre-market Movers
10/27/20
Fly Intel: Pre-market Movers
09/10/20
Spotify upgrade, Ulta Beauty initiation among today's top calls on Wall Street
09/09/20
Netflix resumption, Peloton target raises among today's top calls on Wall Street
SHW Sherwin-Williams
$693.88 /

+12.15 (+1.78%)

10/02/20
On The Fly: ETF fund flow highlights
Hot Stocks
AxoGen promotes Peter Mariani to CFO » 16:31
03/01/21
03/01
16:31
03/01/21
16:31
AXGN

AxoGen

$22.59 /

+0.33 (+1.48%)

Axogen announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXGN AxoGen
$22.59 /

+0.33 (+1.48%)

02/18/21
AxoGen-sponsored REPOSE study completes pilot phase analysis
AXGN AxoGen
$22.59 /

+0.33 (+1.48%)

01/12/21 Cantor Fitzgerald
AxoGen price target raised to $23 from $16 at Cantor Fitzgerald
10/22/20 Guggenheim
AxoGen initiated with a Buy at Guggenheim
06/16/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
AXGN AxoGen
$22.59 /

+0.33 (+1.48%)

02/22/21
AxoGen reports Q4 adjusted EPS (8c), consensus (12c)
01/11/21
AxoGen sees 2020 revenue at least $112.2M, consensus $109.33M
01/11/21
AxoGen sees Q4 revenue at least $32.4M, consensus $29.52M
10/29/20
AxoGen reports Q3 EPS 4c, consensus (14c)
Downgrade
Athenex downgraded to Market Perform from Outperform at SVB Leerink » 16:31
03/01/21
03/01
16:31
03/01/21
16:31
ATNX

Athenex

$5.47 /

-6.715 (-55.11%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATNX Athenex
$5.47 /

-6.715 (-55.11%)

07:35 Today
Athenex trading resumes
07:22 Today
Athenex expects cash to fund operations into 2Q22
07:21 Today
Athenex announces key anticipated future milestones
07:08 Today
FDA requests new study from Athenex for oral paclitaxel plus encequidar
ATNX Athenex
$5.47 /

-6.715 (-55.11%)

16:27 Today JPMorgan
Athenex downgraded to Neutral from Overweight at JPMorgan
13:53 Today Laidlaw
Athenex price target lowered to $13 from $38 at Laidlaw
13:48 Today Needham
Athenex downgraded to Hold from Buy at Needham
02/10/21
Fly Intel: Top five analyst initiations
ATNX Athenex
$5.47 /

-6.715 (-55.11%)

07:21 Today
Athenex reports Q4 adjusted EPS (43c), consensus (44c)
11/05/20
Athenex sees 2020 y-o-y product sales growth in low twenties percentage growth
11/05/20
Athenex reports Q3 EPS (44c), consensus (43c)
  • 10
    Sep
ATNX Athenex
$5.47 /

-6.715 (-55.11%)

12:23 Today
Fly Intel: Wall Street's top stories at midday
09:15 Today
Fly Intel: Pre-market Movers
12/15/20
Fly Intel: Pre-market Movers
09/21/20
Fly Insider: Kingsway Financial, Nvidia among week's notable insider trades
08:00 Today
Athenex - ATNX
Hot Stocks
Invitation Homes names new Chief Investment Officer » 16:30
03/01/21
03/01
16:30
03/01/21
16:30
INVH

Invitation Homes

$29.34 /

+0.095 (+0.32%)

Invitation Homes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INVH Invitation Homes
$29.34 /

+0.095 (+0.32%)

02/16/21
Invitation Homes CEO says 'momentum positions us well for growth in 2021'
01/29/21
Invitation Homes raises dividend 13.3% to 17c
10/07/20
Invitation Homes enters $375M JV with Rockpoint Group
09/15/20
Invitation Homes chairman sells 50,000 common shares
INVH Invitation Homes
$29.34 /

+0.095 (+0.32%)

02/18/21 B. Riley Securities
Invitation Homes price target raised to $35 from $34 at B. Riley Securities
02/16/21 Credit Suisse
Invitation Homes assumed with an Outperform at Credit Suisse
01/20/21 Evercore ISI
Invitation Homes downgraded to In Line from Outperform at Evercore ISI
01/20/21 Evercore ISI
Invitation Homes downgraded to In Line from Outperform at Evercore ISI
INVH Invitation Homes
$29.34 /

+0.095 (+0.32%)

02/16/21
Invitation Homes reports Q4 EPS 12c, consensus 6c
10/28/20
Invitation Homes reports Q3 core FFO 30c, consensus 31c
  • 02
    Jun
Earnings
MercadoLibre reports Q4 EPS ($1.02), consensus 5c » 16:30
03/01/21
03/01
16:30
03/01/21
16:30
MELI

MercadoLibre

$1,715.90 /

+80.81 (+4.94%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MELI MercadoLibre
$1,715.90 /

+80.81 (+4.94%)

02/16/21
Lone Pine bought Snap and Carvana during Q4, exited PayPal
01/07/21
MercadoLibre announces repurchase of $440M convertible senior notes
11/24/20
Amazon Web Services selected by MercadoLibre as primary cloud provider
MELI MercadoLibre
$1,715.90 /

+80.81 (+4.94%)

08:54 Today Credit Suisse
MercadoLibre price target raised to $1,925 from $1,555 at Credit Suisse
02/11/21
Fly Intel: Top five analyst initiations
02/11/21 Scotiabank
Scotiabank starts MercadoLibre at neutral, awaits better entry point
02/11/21 Scotiabank
MercadoLibre initiated with a Sector Perform at Scotiabank
MELI MercadoLibre
$1,715.90 /

+80.81 (+4.94%)

11/04/20
MercadoLibre reports Q3 EPS 28c, consensus 17c
MELI MercadoLibre
$1,715.90 /

+80.81 (+4.94%)

11/04/20
Fly Intel: After-Hours Movers
16:30 Today
MercadoLibre - MELI
03/08/21
MercadoLibre
03/09/21
MercadoLibre
Options
Preliminary option volume of 37.6M today » 16:30
03/01/21
03/01
16:30
03/01/21
16:30

Preliminary option volume…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Repay Holdings sees FY21 revenue $178M-$188M, consensus $185.48M » 16:29
03/01/21
03/01
16:29
03/01/21
16:29
RPAY

Repay Holdings

$22.59 /

+0.79 (+3.62%)

Sees FY21 card payment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RPAY Repay Holdings
$22.59 /

+0.79 (+3.62%)

01/20/21
Repay Holdings announces technology integration with Billtrust
12/07/20
Repay Holdings announces partnership with SHRO
10/27/20
Repay Holdings to acquire CPS Payment Services for up to $93M
10/07/20
Repay announces integration with Ellie Mae
RPAY Repay Holdings
$22.59 /

+0.79 (+3.62%)

01/20/21 Wells Fargo
Repay Holdings initiated with an Equal Weight at Wells Fargo
10/05/20 Morgan Stanley
Repay Holdings initiated with an Equal Weight at Morgan Stanley
09/17/20 Barclays
Repay Holdings initiated with an Overweight at Barclays
08/11/20 Canaccord
Repay Holdings price target raised to $30 from $26 at Canaccord
RPAY Repay Holdings
$22.59 /

+0.79 (+3.62%)

16:07 Today
Repay Holdings reports Q4 adjusted EPS 17c, consensus 11c
11/09/20
Repay Holdings reports Q3 adjusted EPS 12c
  • 14
    Jan
  • 10
    Sep
  • 29
    May
17:00 Today
Repay Holdings - RPAY
03/18/21
Repay Holdings
Syndicate
WillScot Mobile Mini files to sell 59.68M shares of common stock for holders  16:28
03/01/21
03/01
16:28
03/01/21
16:28
WSC

WillScot Mobile Mini

$27.76 /

+0.05 (+0.18%)

 
ShowHide Related Items >><<
WSC WillScot Mobile Mini
$27.76 /

+0.05 (+0.18%)

02/16/21
Cooperman's Omega Advisors buys GM, exits Lee in Q4
WSC WillScot Mobile Mini
$27.76 /

+0.05 (+0.18%)

02/02/21 Deutsche Bank
WillScot Mobile Mini price target raised to $26 from $22 at Deutsche Bank
01/26/21 DA Davidson
WillScot Mobile Mini price target raised to $30 from $25 at DA Davidson
01/13/21 Oppenheimer
WillScot Mobile Mini price target raised to $29 from $24 at Oppenheimer
11/10/20 Barclays
WillScot Mobile Mini reinstated with an Equal Weight at Barclays
WSC WillScot Mobile Mini
$27.76 /

+0.05 (+0.18%)

02/25/21
WillScot Mobile Mini sees FY21 revenue $1.7B-$1.8B, consensus $1.71B
02/25/21
WillScot Mobile Mini reports Q4 revenue $437.65M, consensus $421.14M
11/05/20
WillScot Mobile Mini sees FY20 revenue $1.32B-$1.37B, down from $1.32B-$.42B
11/05/20
WillScot Mobile Mini reports Q3 EPS 7c, consensus 7c
WSC WillScot Mobile Mini
$27.76 /

+0.05 (+0.18%)

10/21/20
WillScot Mobile Mini pitched as long idea by Dendur's Mac Levine
05/18/21
WillScot Mobile Mini
Earnings
OraSure reports Q4 EPS 3c, consensus 7c » 16:28
03/01/21
03/01
16:28
03/01/21
16:28
OSUR

OraSure

$11.08 /

+0.42 (+3.94%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OSUR OraSure
$11.08 /

+0.42 (+3.94%)

01/29/21
OraSure's OM-505 saliva collection kit included in EUA granted to Ambry
01/28/21
OraSure's saliva collection device authorized by Health Canada for COVID-19 test
01/26/21
Chronomics selects OraSure's OMNIgene ORAL salive collection kit
01/21/21
OraSure's saliva collection kit Included in FDA authorization for exome platform
OSUR OraSure
$11.08 /

+0.42 (+3.94%)

12/22/20 Lake Street
Lake Street says OraSure test news disappointing, not due to fundamental issues
08/21/20
Fly Intel: Top five analyst initiations
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
OSUR OraSure
$11.08 /

+0.42 (+3.94%)

11/04/20
OraSure reports Q EPS 1c, consensus (7c)
  • 03
    Jun
OSUR OraSure
$11.08 /

+0.42 (+3.94%)

12/23/20
Fly Intel: Pre-market Movers
11/04/20
Fly Intel: After-Hours Movers
10/19/20
Fly Intel: Pre-market Movers
17:00 Today
OraSure - OSUR
OSUR OraSure
$11.08 /

+0.42 (+3.94%)

11/04/20
OraSure options imply 19.8% move in share price post-earnings
Downgrade
Athenex downgraded to Neutral from Overweight at JPMorgan » 16:27
03/01/21
03/01
16:27
03/01/21
16:27
ATNX

Athenex

$5.47 /

-6.715 (-55.11%)

JPMorgan analyst Ling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATNX Athenex
$5.47 /

-6.715 (-55.11%)

07:35 Today
Athenex trading resumes
07:22 Today
Athenex expects cash to fund operations into 2Q22
07:21 Today
Athenex announces key anticipated future milestones
07:08 Today
FDA requests new study from Athenex for oral paclitaxel plus encequidar
ATNX Athenex
$5.47 /

-6.715 (-55.11%)

13:53 Today Laidlaw
Athenex price target lowered to $13 from $38 at Laidlaw
13:48 Today Needham
Athenex downgraded to Hold from Buy at Needham
02/10/21
Fly Intel: Top five analyst initiations
02/10/21 Evercore ISI
Athenex initiated with an Outperform at Evercore ISI
ATNX Athenex
$5.47 /

-6.715 (-55.11%)

07:21 Today
Athenex reports Q4 adjusted EPS (43c), consensus (44c)
11/05/20
Athenex sees 2020 y-o-y product sales growth in low twenties percentage growth
11/05/20
Athenex reports Q3 EPS (44c), consensus (43c)
  • 10
    Sep
ATNX Athenex
$5.47 /

-6.715 (-55.11%)

12:23 Today
Fly Intel: Wall Street's top stories at midday
09:15 Today
Fly Intel: Pre-market Movers
12/15/20
Fly Intel: Pre-market Movers
09/21/20
Fly Insider: Kingsway Financial, Nvidia among week's notable insider trades
08:00 Today
Athenex - ATNX
Hot Stocks
Delek US names Todd O'Malley EVP and Chief Commercial Officer » 16:27
03/01/21
03/01
16:27
03/01/21
16:27
DK

Delek US

$23.89 /

-0.71 (-2.89%)

Delek US Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DK Delek US
$23.89 /

-0.71 (-2.89%)

14:54 Today
Delek US says will review letter received from CVR, 'respond in due course'
02/23/21
Delek US expects to increase FY21 distribution by 5%
02/03/21
Delek US to evaluate CVR Energy's director nominees
01/14/21
Delek US says board committee to evaluate any CVR nominees
DK Delek US
$23.89 /

-0.71 (-2.89%)

02/26/21 Mizuho
Delek US downgraded to Neutral from Buy at Mizuho
02/25/21 Wells Fargo
Delek US price target raised to $31 from $25 at Wells Fargo
02/22/21 Citi
Delek US price target raised to $26 from $16 at Citi
01/26/21 Goldman Sachs
Delek US downgraded to Sell from Neutral at Goldman Sachs
DK Delek US
$23.89 /

-0.71 (-2.89%)

02/23/21
Delek US reports Q4 adjusted EPS ($2.77), consensus ($1.92)
11/04/20
Delek US reports Q3 adjusted EPS ($1.01), consensus ($1.38)
DK Delek US
$23.89 /

-0.71 (-2.89%)

12/30/20
Dallas Fed survey sees about half of U.S. energy co's expect '21 capex boost
09/16/20
White House mulls at least $300M in aid to U.S. oil refiners, Reuters says
DK Delek US
$23.89 /

-0.71 (-2.89%)

09/19/20
Week in review: How Trump's policies moved stocks
00:00 Today
26th Annual Energy Virtual Summit
Syndicate
First Republic 1.5M share Spot Secondary; price range $166.50-$169.95 » 16:27
03/01/21
03/01
16:27
03/01/21
16:27
FRC

First Republic

$172.57 /

+7.815 (+4.74%)

false:BOFA, JPMS &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRC First Republic
$172.57 /

+7.815 (+4.74%)

01/15/21 Maxim
First Republic price target raised to $200 from $195 at Maxim
01/15/21 Citi
First Republic price target raised to $163 from $141 at Citi
01/04/21 Barclays
First Republic price target raised to $156 from $130 at Barclays
12/31/20 Compass Point
Compass Point raises price target on 'top pick' First Republic to $165
FRC First Republic
$172.57 /

+7.815 (+4.74%)

01/14/21
First Republic reports Q4 EPS $1.60, consensus $1.52
01/13/21
Notable companies reporting before tomorrow's open
10/13/20
First Republic reports Q3 EPS $1.61, consensus $1.39
  • 12
    Nov
FRC First Republic
$172.57 /

+7.815 (+4.74%)

01/14/21
Fly Intel: Pre-market Movers
Conference/Events
United Airlines participates in a conference call with Cowen » 16:26
03/01/21
03/01
16:26
03/01/21
16:26
UAL

United Airlines

$53.31 /

+0.63 (+1.20%)

Aerospace & Defense…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UAL United Airlines
$53.31 /

+0.63 (+1.20%)

02/26/21
United Airlines to settle Postal Service probe for $49M
02/21/21
Fly Intel: Top five weekend stock stories
02/19/21
United Airlines plans new nonstop service between Boston Logan, London Heathrow
02/16/21
XpresSpa announces second XpressCheck Covid testing facility at Newark
UAL United Airlines
$53.31 /

+0.63 (+1.20%)

02/22/21
Fly Intel: Top five analyst upgrades
02/22/21 Deutsche Bank
Deutsche upgrades eight airlines with Covid trending in right direction
02/22/21 Deutsche Bank
United Airlines upgraded to Buy from Hold at Deutsche Bank
02/17/21 BofA
Mesa Air double-upgraded to Buy from Underperform at BofA
UAL United Airlines
$53.31 /

+0.63 (+1.20%)

01/20/21
United Airlines ended 2020 with $19.7B in available liquidity
01/20/21
United sees Q1 operating revenue down 65%-70%, consensus $4.06B
01/20/21
United Airlines reports Q4 adjusted EPS ($7.00), consensus ($6.60)
01/20/21
Notable companies reporting after market close
  • 22
    Apr
UAL United Airlines
$53.31 /

+0.63 (+1.20%)

02/23/21
Pratt & Whitney-made 777 engines already faced new scrutiny, WSJ reports
02/21/21
United to temporarily stop flying some Boeing 777 planes, Reuters reports
02/21/21
United flight sheds debris over Colorado following engine failure, NY Times says
01/31/21
CDC orders sweeping transportation mask mandate, Reuters reports
UAL United Airlines
$53.31 /

+0.63 (+1.20%)

02/22/21
Fly Intel: Wall Street's top stories for Monday
02/22/21
Fly Intel: Wall Street's top stories at midday
02/22/21
Airbnb, Snap upgrades among today's top calls on Wall Street
02/22/21
Fly Intel: Pre-market Movers
03/09/21
United Airlines - UAL
UAL United Airlines
$53.31 /

+0.63 (+1.20%)

02/25/21
Unusually active option classes on open February 25th
02/24/21
Early notable gainers among liquid option names on February 24th
02/22/21
Unusually active option classes on open February 22nd
02/19/21
United Continental call volume above normal and directionally bullish
Earnings
Nephros reports Q4 revenue $2.3M, consensus $2.34M » 16:26
03/01/21
03/01
16:26
03/01/21
16:26
NEPH

Nephros

$8.19 /

+0.54 (+7.06%)

Reports Q4 adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NEPH Nephros
$8.19 /

+0.54 (+7.06%)

02/18/21
Nephros appoints Wes Lobo as CMO
01/04/21
Nephros expects to file HDF2 Special 510(k) in early 2021
10/13/20
Nephros announces release of DialyPath endotoxin assay
NEPH Nephros
$8.19 /

+0.54 (+7.06%)

01/26/21 B. Riley Securities
Nephros initiated with a Buy, $12.50 target at B. Riley Securities
01/26/21 B. Riley Securities
Nephros initiated with a Buy at B. Riley Securities
NEPH Nephros
$8.19 /

+0.54 (+7.06%)

01/12/21
Nephros reports preliminary 2020 revenue $8.5M, consensus $8.56M
01/12/21
Nephros reports preliminary Q4 revenue $2.3M, consensus $2.31M
10/06/20
Nephros sees Q3 revenue $2.1M, consensus $2.18M
16:30 Today
Nephros - NEPH
Initiation
Freeline initiated with a Buy at Stifel » 16:26
03/01/21
03/01
16:26
03/01/21
16:26
FRLN

Freeline

$15.00 /

+ (+0.00%)

Stifel analyst Dae Gon Ha…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FRLN Freeline
$15.00 /

+ (+0.00%)

02/16/21
Freeline CFO Brian Silver to depart
02/16/21
Freeline appoints Michael Parini as president, COO
02/09/21
Aquestive Therapeutics appoints Julie Krop, Marco Taglietti to board
02/08/21
Freeline to highlight data from Gaucher and Fabry disease gene therapy program
FRLN Freeline
$15.00 /

+ (+0.00%)

11/25/20 Redburn
Freeline initiated with a Neutral at Redburn
09/01/20 Evercore ISI
Freeline initiated with an Outperform at Evercore ISI
09/01/20 Wedbush
Wedbush bullish on Freeline, initiates with an Outperform
09/01/20 Wedbush
Freeline initiated with an Outperform at Wedbush
  • 07
    Aug
Syndicate
Hamilton Lane announces offering of 1.45M shares of Class A common stock » 16:25
03/01/21
03/01
16:25
03/01/21
16:25
HLNE

Hamilton Lane

$91.73 /

+2.24 (+2.50%)

Hamilton Lane…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HLNE Hamilton Lane
$91.73 /

+2.24 (+2.50%)

02/16/21
Hamilton Lane closes largest fund to-date
01/28/21
Hamilton Lane to acquire Denver-based 361 Capital
01/07/21
Hamilton Lane launches fund to expand access to private markets
HLNE Hamilton Lane
$91.73 /

+2.24 (+2.50%)

01/26/21 Morgan Stanley
Morgan Stanley downgrades Hamilton Lane to Equal Weight following outperformance
01/26/21 Morgan Stanley
Hamilton Lane downgraded to Equal Weight from Overweight at Morgan Stanley
01/11/21 Wells Fargo
Hamilton Lane price target raised to $77 from $70 at Wells Fargo
12/16/20 UBS
Hamilton Lane initiated with a Buy at UBS
HLNE Hamilton Lane
$91.73 /

+2.24 (+2.50%)

02/02/21
Hamilton Lane reports Q3 EPS 96c, consensus 57c
11/04/20
Hamilton Lane reports Q2 EPS 66c, consensus 60c
  • 02
    Sep
  • 03
    Jun
Earnings
Agile Therapeutics reports Q EPS (20c), consensus (22c) » 16:25
03/01/21
03/01
16:25
03/01/21
16:25
AGRX

Agile Therapeutics

$3.02 /

+0.145 (+5.05%)

Reports Q4 revenue $1M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGRX Agile Therapeutics
$3.02 /

+0.145 (+5.05%)

12/07/20
Agile Therapeutics announces nationwide commercial launch of Twirla
11/30/20
Agile Therapeutics announces publication of Phase 3 SECURE results for Twirla
11/12/20
Agile Therapeutics sees FY20 operating expense $52M-$54M
AGRX Agile Therapeutics
$3.02 /

+0.145 (+5.05%)

12/08/20 H.C. Wainwright
Agile Therapeutics price target raised to $7 from $6 at H.C. Wainwright
09/22/20 H.C. Wainwright
H.C. Wainwright says Agile coverage, access for Twirla launch underappreciated
03/20/20 H.C. Wainwright
H.C. Wainwright 'strongly' reiterates Buy on Agile Therapeutics
AGRX Agile Therapeutics
$3.02 /

+0.145 (+5.05%)

11/12/20
Agile Therapeutics reports Q3 EPS (18c), consensus (18c)
03/04/21
M-Vest Virtual Conference Series: Late Stage Innovations in Women's Health
03/16/21
31st Annual Healthcare Virtual Conference
16:30 Today
Agile Therapeutics - AGRX
Earnings
Ooma sees FY22 EPS 26c-34c, consensus 39c » 16:24
03/01/21
03/01
16:24
03/01/21
16:24
OOMA

Ooma

$16.41 /

+0.47 (+2.95%)

Sees FY22 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OOMA Ooma
$16.41 /

+0.47 (+2.95%)

01/11/21 Alliance Global Partners
Ooma has not participated in small cap rally, says Alliance Global Partners
11/20/20 B. Riley Securities
Ooma price target raised to $23.50 from $22 at B. Riley Securities
11/20/20 Alliance Global Partners
Ooma price target raised to $24 from $22 at Alliance Global Partners
07/22/20
Fly Intel: Top five analyst initiations
OOMA Ooma
$16.41 /

+0.47 (+2.95%)

16:23 Today
Ooma sees Q1 EPS 7c-10c, consensus 8c
16:23 Today
Ooma reports Q4 EPS 12c, consensus 10c
11/19/20
Ooma raises FY21 EPS view to 45c-47c from 34c-40c, consensus 38c
11/19/20
Ooma sees Q4 EPS 8c-11c, consensus 6c
03/15/21
33rd Annual Roth Virtual Conference
00:00 Today
Ooma - OOMA
17:00 Today
Ooma - OOMA
Syndicate
SelectQuote announces offering of 10.6M shares of common stock for holders » 16:24
03/01/21
03/01
16:24
03/01/21
16:24
SLQT

SelectQuote

$32.21 /

+1.71 (+5.61%)

SelectQuote announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLQT SelectQuote
$32.21 /

+1.71 (+5.61%)

02/10/21 Citi
SelectQuote price target raised to $34 from $32 at Citi
02/09/21 Evercore ISI
SelectQuote price target raised to $38 from $35 at Evercore ISI
02/09/21 Barclays
SelectQuote price target raised to $36 from $32 at Barclays
10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
SLQT SelectQuote
$32.21 /

+1.71 (+5.61%)

02/08/21
SelectQuote raises FY21 revenue view to $920M-$940M from $840M-$880M
02/08/21
SelectQuote reports Q2 EPS 55c, consensus 44c
11/05/20
SelectQuote raises FY21 revenue view to $840M-$880M from $775M-$815M
11/05/20
SelectQuote reports Q1 EPS 1c, consensus (4c)
  • 21
    May
SLQT SelectQuote
$32.21 /

+1.71 (+5.61%)

02/08/21
Fly Intel: After-Hours Movers
11/16/20
Fly Intel: What to watch in Walmart's earnings report
09/10/20
Fly Intel: Pre-market Movers
09/09/20
Fly Intel: After-Hours Movers
SLQT SelectQuote
$32.21 /

+1.71 (+5.61%)

02/08/21
SelectQuote options imply 13.0% move in share price post-earnings
01/19/21
Unusual call flow in option market yesterday
01/15/21
SelectQuote call buyer as shares jump
Earnings
Ooma sees Q1 EPS 7c-10c, consensus 8c » 16:23
03/01/21
03/01
16:23
03/01/21
16:23
OOMA

Ooma

$16.41 /

+0.47 (+2.95%)

Sees Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OOMA Ooma
$16.41 /

+0.47 (+2.95%)

01/11/21 Alliance Global Partners
Ooma has not participated in small cap rally, says Alliance Global Partners
11/20/20 B. Riley Securities
Ooma price target raised to $23.50 from $22 at B. Riley Securities
11/20/20 Alliance Global Partners
Ooma price target raised to $24 from $22 at Alliance Global Partners
07/22/20
Fly Intel: Top five analyst initiations
OOMA Ooma
$16.41 /

+0.47 (+2.95%)

16:23 Today
Ooma reports Q4 EPS 12c, consensus 10c
11/19/20
Ooma raises FY21 EPS view to 45c-47c from 34c-40c, consensus 38c
11/19/20
Ooma sees Q4 EPS 8c-11c, consensus 6c
11/19/20
Ooma reports Q3 EPS 13c, consensus 8c
03/15/21
33rd Annual Roth Virtual Conference
00:00 Today
Ooma - OOMA
17:00 Today
Ooma - OOMA
Earnings
SeaSpine reports Q4 EPS (37c), consensus (26c) » 16:23
03/01/21
03/01
16:23
03/01/21
16:23
SPNE

SeaSpine

$20.42 /

+1.42 (+7.47%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPNE SeaSpine
$20.42 /

+1.42 (+7.47%)

08:18 Today
SeaSpine announces full commercial launch of Reef TO Interbody System
02/22/21
SeaSpine announces limited commercial launch of WaveForm system
01/20/21
SeaSpine announces limited commercial launch of Regatta Lateral Plate System
12/15/20
SeaSpine announces FDA 510(k) clearance for NanoMetalene indication
SPNE SeaSpine
$20.42 /

+1.42 (+7.47%)

01/29/21 Piper Sandler
SeaSpine price target raised to $22 from $18 at Piper Sandler
01/11/21 Piper Sandler
SeaSpine should be bought on any weakness today, says Piper Sandler
10/19/20 Stifel
SeaSpine initiated with a Buy at Stifel
10/06/20 Piper Sandler
SeaSpine remains 'must-own SMID-cap name,' says Piper Sandler
SPNE SeaSpine
$20.42 /

+1.42 (+7.47%)

01/11/21
SeaSpine sees FY20 revenue $154.1M-$154.5M, consensus $155.18M
01/11/21
SeaSpine reports preliminary Q4 revenue $46.2M-$46.2M, consensus $47.27M
11/09/20
SeaSpine reports Q3 EPS (24c), consensus (31c)
10/06/20
SeaSpine sees Q4 revenue $47M-$48M, consensus $45.14M
SPNE SeaSpine
$20.42 /

+1.42 (+7.47%)

10/19/20
Fly Intel: After-Hours Movers
16:30 Today
SeaSpine - SPNE
03/05/21
SeaSpine
03/19/21
SeaSpine
Earnings
Ooma reports Q4 EPS 12c, consensus 10c » 16:23
03/01/21
03/01
16:23
03/01/21
16:23
OOMA

Ooma

$16.41 /

+0.47 (+2.95%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OOMA Ooma
$16.41 /

+0.47 (+2.95%)

01/11/21 Alliance Global Partners
Ooma has not participated in small cap rally, says Alliance Global Partners
11/20/20 B. Riley Securities
Ooma price target raised to $23.50 from $22 at B. Riley Securities
11/20/20 Alliance Global Partners
Ooma price target raised to $24 from $22 at Alliance Global Partners
07/22/20
Fly Intel: Top five analyst initiations
OOMA Ooma
$16.41 /

+0.47 (+2.95%)

11/19/20
Ooma raises FY21 EPS view to 45c-47c from 34c-40c, consensus 38c
11/19/20
Ooma sees Q4 EPS 8c-11c, consensus 6c
11/19/20
Ooma reports Q3 EPS 13c, consensus 8c
03/15/21
33rd Annual Roth Virtual Conference
00:00 Today
Ooma - OOMA
17:00 Today
Ooma - OOMA

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.